ESTEE LAUDER COMPANIES-CL A (1ELX.MI) Stock Fundamental Analysis

BIT:1ELX • US5184391044

92.6 EUR
+5.6 (+6.44%)
Last: Feb 17, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to 1ELX. 1ELX was compared to 16 industry peers in the Personal Care Products industry. 1ELX has a medium profitability rating, but doesn't score so well on its financial health evaluation. 1ELX is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • 1ELX had positive earnings in the past year.
  • In the past year 1ELX had a positive cash flow from operations.
  • Of the past 5 years 1ELX 4 years were profitable.
  • 1ELX had a positive operating cash flow in each of the past 5 years.
1ELX.MI Yearly Net Income VS EBIT VS OCF VS FCF1ELX.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B 2B 3B

1.2 Ratios

  • With a Return On Assets value of -0.91%, 1ELX is not doing good in the industry: 68.75% of the companies in the same industry are doing better.
  • 1ELX has a Return On Equity of -4.42%. This is in the lower half of the industry: 1ELX underperforms 68.75% of its industry peers.
  • 1ELX has a Return On Invested Capital of 5.19%. This is in the lower half of the industry: 1ELX underperforms 75.00% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for 1ELX is significantly below the industry average of 11.28%.
  • The last Return On Invested Capital (5.19%) for 1ELX is above the 3 year average (4.98%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -0.91%
ROE -4.42%
ROIC 5.19%
ROA(3y)0.13%
ROA(5y)4.98%
ROE(3y)-1.32%
ROE(5y)17.24%
ROIC(3y)4.98%
ROIC(5y)7.4%
1ELX.MI Yearly ROA, ROE, ROIC1ELX.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40

1.3 Margins

  • 1ELX has a Operating Margin (9.59%) which is comparable to the rest of the industry.
  • 1ELX's Operating Margin has declined in the last couple of years.
  • With an excellent Gross Margin value of 74.33%, 1ELX belongs to the best of the industry, outperforming 93.75% of the companies in the same industry.
  • In the last couple of years the Gross Margin of 1ELX has remained more or less at the same level.
Industry RankSector Rank
OM 9.59%
PM (TTM) N/A
GM 74.33%
OM growth 3Y-26.29%
OM growth 5Y-11.55%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.76%
GM growth 5Y-0.3%
1ELX.MI Yearly Profit, Operating, Gross Margins1ELX.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), 1ELX is destroying value.
  • The number of shares outstanding for 1ELX has been increased compared to 1 year ago.
  • 1ELX has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for 1ELX is higher compared to a year ago.
1ELX.MI Yearly Shares Outstanding1ELX.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
1ELX.MI Yearly Total Debt VS Total Assets1ELX.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

2.2 Solvency

  • 1ELX has an Altman-Z score of 3.45. This indicates that 1ELX is financially healthy and has little risk of bankruptcy at the moment.
  • 1ELX has a Altman-Z score (3.45) which is comparable to the rest of the industry.
  • 1ELX has a debt to FCF ratio of 6.44. This is a slightly negative value and a sign of low solvency as 1ELX would need 6.44 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 6.44, 1ELX is doing worse than 62.50% of the companies in the same industry.
  • A Debt/Equity ratio of 1.82 is on the high side and indicates that 1ELX has dependencies on debt financing.
  • 1ELX has a Debt to Equity ratio of 1.82. This is amonst the worse of the industry: 1ELX underperforms 81.25% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.82
Debt/FCF 6.44
Altman-Z 3.45
ROIC/WACC0.69
WACC7.55%
1ELX.MI Yearly LT Debt VS Equity VS FCF1ELX.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B

2.3 Liquidity

  • 1ELX has a Current Ratio of 1.36. This is a normal value and indicates that 1ELX is financially healthy and should not expect problems in meeting its short term obligations.
  • 1ELX has a Current ratio (1.36) which is comparable to the rest of the industry.
  • 1ELX has a Quick Ratio of 1.36. This is a bad value and indicates that 1ELX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • 1ELX has a Quick ratio (1.00) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.36
Quick Ratio 1
1ELX.MI Yearly Current Assets VS Current Liabilites1ELX.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • The earnings per share for 1ELX have decreased strongly by -17.72% in the last year.
  • The earnings per share for 1ELX have been decreasing by -18.22% on average. This is quite bad
  • Looking at the last year, 1ELX shows a decrease in Revenue. The Revenue has decreased by -3.35% in the last year.
  • 1ELX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.04% yearly.
EPS 1Y (TTM)-17.72%
EPS 3Y-40.77%
EPS 5Y-18.22%
EPS Q2Q%43.55%
Revenue 1Y (TTM)-3.35%
Revenue growth 3Y-6.88%
Revenue growth 5Y0.04%
Sales Q2Q%5.62%

3.2 Future

  • 1ELX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 28.85% yearly.
  • Based on estimates for the next years, 1ELX will show a small growth in Revenue. The Revenue will grow by 4.55% on average per year.
EPS Next Y48.01%
EPS Next 2Y43.32%
EPS Next 3Y36.97%
EPS Next 5Y28.85%
Revenue Next Year4.29%
Revenue Next 2Y4.14%
Revenue Next 3Y4.3%
Revenue Next 5Y4.55%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
1ELX.MI Yearly Revenue VS Estimates1ELX.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B 15B
1ELX.MI Yearly EPS VS Estimates1ELX.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 56.12, the valuation of 1ELX can be described as expensive.
  • Based on the Price/Earnings ratio, 1ELX is valued a bit more expensive than 75.00% of the companies in the same industry.
  • 1ELX is valuated expensively when we compare the Price/Earnings ratio to 27.27, which is the current average of the S&P500 Index.
  • A Price/Forward Earnings ratio of 35.60 indicates a quite expensive valuation of 1ELX.
  • Based on the Price/Forward Earnings ratio, 1ELX is valued more expensive than 81.25% of the companies in the same industry.
  • 1ELX is valuated rather expensively when we compare the Price/Forward Earnings ratio to 28.16, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 56.12
Fwd PE 35.6
1ELX.MI Price Earnings VS Forward Price Earnings1ELX.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, 1ELX is valued more expensive than 81.25% of the companies in the same industry.
  • 1ELX's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 34.9
EV/EBITDA 19.81
1ELX.MI Per share data1ELX.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • 1ELX's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • 1ELX's earnings are expected to grow with 36.97% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.17
PEG (5Y)N/A
EPS Next 2Y43.32%
EPS Next 3Y36.97%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for 1ELX!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ESTEE LAUDER COMPANIES-CL A

BIT:1ELX (2/17/2026, 7:00:00 PM)

92.6

+5.6 (+6.44%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)02-05
Earnings (Next)05-01
Inst Owners91.48%
Inst Owner ChangeN/A
Ins Owners0.12%
Ins Owner ChangeN/A
Market Cap33.50B
Revenue(TTM)14.67B
Net Income(TTM)-178.00M
Analysts73.14
Price Target91.04 (-1.68%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend1.45
Dividend Growth(5Y)4.31%
DP-284.83%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)39.67%
Min EPS beat(2)3.39%
Max EPS beat(2)75.96%
EPS beat(4)4
Avg EPS beat(4)44.7%
Min EPS beat(4)0.44%
Max EPS beat(4)99.01%
EPS beat(8)8
Avg EPS beat(8)67.28%
EPS beat(12)11
Avg EPS beat(12)85.85%
EPS beat(16)15
Avg EPS beat(16)67.66%
Revenue beat(2)0
Avg Revenue beat(2)-1.44%
Min Revenue beat(2)-2.83%
Max Revenue beat(2)-0.06%
Revenue beat(4)0
Avg Revenue beat(4)-1.87%
Min Revenue beat(4)-2.83%
Max Revenue beat(4)-0.06%
Revenue beat(8)0
Avg Revenue beat(8)-2.05%
Revenue beat(12)1
Avg Revenue beat(12)-1.74%
Revenue beat(16)2
Avg Revenue beat(16)-1.86%
PT rev (1m)5.03%
PT rev (3m)12.33%
EPS NQ rev (1m)-11.51%
EPS NQ rev (3m)-10.84%
EPS NY rev (1m)0.23%
EPS NY rev (3m)0.87%
Revenue NQ rev (1m)-0.63%
Revenue NQ rev (3m)-0.52%
Revenue NY rev (1m)0.08%
Revenue NY rev (3m)0.4%
Valuation
Industry RankSector Rank
PE 56.12
Fwd PE 35.6
P/S 2.7
P/FCF 34.9
P/OCF 23.76
P/B 9.84
P/tB N/A
EV/EBITDA 19.81
EPS(TTM)1.65
EY1.78%
EPS(NY)2.6
Fwd EY2.81%
FCF(TTM)2.65
FCFY2.87%
OCF(TTM)3.9
OCFY4.21%
SpS34.23
BVpS9.41
TBVpS-4.21
PEG (NY)1.17
PEG (5Y)N/A
Graham Number18.69
Profitability
Industry RankSector Rank
ROA -0.91%
ROE -4.42%
ROCE 9.79%
ROIC 5.19%
ROICexc 6.6%
ROICexgc 13.67%
OM 9.59%
PM (TTM) N/A
GM 74.33%
FCFM 7.75%
ROA(3y)0.13%
ROA(5y)4.98%
ROE(3y)-1.32%
ROE(5y)17.24%
ROIC(3y)4.98%
ROIC(5y)7.4%
ROICexc(3y)6.37%
ROICexc(5y)9.94%
ROICexgc(3y)15.14%
ROICexgc(5y)22.74%
ROCE(3y)9.4%
ROCE(5y)13.97%
ROICexgc growth 3Y-33.25%
ROICexgc growth 5Y-18.06%
ROICexc growth 3Y-32.16%
ROICexc growth 5Y-18.64%
OM growth 3Y-26.29%
OM growth 5Y-11.55%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.76%
GM growth 5Y-0.3%
F-Score5
Asset Turnover0.75
Health
Industry RankSector Rank
Debt/Equity 1.82
Debt/FCF 6.44
Debt/EBITDA 3.3
Cap/Depr 65.72%
Cap/Sales 3.63%
Interest Coverage 4.11
Cash Conversion 75.33%
Profit Quality N/A
Current Ratio 1.36
Quick Ratio 1
Altman-Z 3.45
F-Score5
WACC7.55%
ROIC/WACC0.69
Cap/Depr(3y)208.69%
Cap/Depr(5y)173.4%
Cap/Sales(3y)10.24%
Cap/Sales(5y)8.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-17.72%
EPS 3Y-40.77%
EPS 5Y-18.22%
EPS Q2Q%43.55%
EPS Next Y48.01%
EPS Next 2Y43.32%
EPS Next 3Y36.97%
EPS Next 5Y28.85%
Revenue 1Y (TTM)-3.35%
Revenue growth 3Y-6.88%
Revenue growth 5Y0.04%
Sales Q2Q%5.62%
Revenue Next Year4.29%
Revenue Next 2Y4.14%
Revenue Next 3Y4.3%
Revenue Next 5Y4.55%
EBIT growth 1Y-5.06%
EBIT growth 3Y-31.36%
EBIT growth 5Y-11.51%
EBIT Next Year108.86%
EBIT Next 3Y38.7%
EBIT Next 5Y26.64%
FCF growth 1Y176.82%
FCF growth 3Y-30.55%
FCF growth 5Y-16.56%
OCF growth 1Y-12.88%
OCF growth 3Y-25.21%
OCF growth 5Y-11.02%

ESTEE LAUDER COMPANIES-CL A / 1ELX.MI FAQ

What is the ChartMill fundamental rating of ESTEE LAUDER COMPANIES-CL A (1ELX.MI) stock?

ChartMill assigns a fundamental rating of 3 / 10 to 1ELX.MI.


What is the valuation status for 1ELX stock?

ChartMill assigns a valuation rating of 2 / 10 to ESTEE LAUDER COMPANIES-CL A (1ELX.MI). This can be considered as Overvalued.


Can you provide the profitability details for ESTEE LAUDER COMPANIES-CL A?

ESTEE LAUDER COMPANIES-CL A (1ELX.MI) has a profitability rating of 4 / 10.


What is the valuation of ESTEE LAUDER COMPANIES-CL A based on its PE and PB ratios?

The Price/Earnings (PE) ratio for ESTEE LAUDER COMPANIES-CL A (1ELX.MI) is 56.12 and the Price/Book (PB) ratio is 9.84.


How sustainable is the dividend of ESTEE LAUDER COMPANIES-CL A (1ELX.MI) stock?

The dividend rating of ESTEE LAUDER COMPANIES-CL A (1ELX.MI) is 0 / 10 and the dividend payout ratio is -284.83%.